Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
29
Number of overlapping holdings
32.6%
% of WDNA's 91 holdings also in BMED
22.5%
% of BMED's 147 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus BMED)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in WDNA |
Weight in BMED |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 1.9% | 1.7% | 1.7% | |
BLUEPRINT MEDICINES CORP. | 2.2% | 1.5% | 1.5% | |
DANAHER CORP | 1.3% | 1.5% | 1.3% | |
MERCK & CO. INC. | 1.1% | 1.3% | 1.1% | |
SAREPTA THERAPEUTICS INC | 1.1% | 1.4% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to BMED
IOVANCE BIOTHERAPEUTICS INC | 3.8% | |
TWIST BIOSCIENCE CORP. | 3.1% | |
FATE THERAPEUTICS INC | 3.1% | |
NOVOZYMES A/S-B SHARES | 2.4% | |
NATERA INC | 1.9% | |
BRIDGEBIO PHARMA, INC. | 1.9% | |
CRISPR THERAPEUTICS AG | 1.8% | |
VERICEL CORPORATION | 1.7% | |
AGIOS PHARMACEUTICALS INC | 1.6% | |
CARIBOU BIOSCIENCES, INC. | 1.6% |
WDNA Underweight Relative to BMED
BOSTON SCIENTIFIC CORP | -3.5% | |
AMERISOURCEBERGEN CORP | -3.1% | |
INTUITIVE SURGICAL INC | -2.3% | |
COOPER COS INC/THE | -2.1% | |
NOVO NORDISK A/S-B | -2.1% | |
ABBVIE INC | -2.1% | |
ALIGN TECHNOLOGY INC | -2.0% | |
WEST PHARMACEUTICAL SERVICES | -2.0% | |
ARGENX SE ADR | -1.8% | |
WATERS CORP | -1.6% |